Dark Chocolate Acutely Improves Walking Autonomy in Patients With Peripheral Artery Disease. Issue 4 (2nd July 2014)

• Record Type: Journal Article
• Authors: Loffredo, Lorenzo; Perri, Ludovica; Catasca, Elisa; Pignatelli, Pasquale; Brancorsini, Monica; Nocella, Cristina; De Falco, Elena; Bartimoccia, Simona; Frati, Giacomo; Carnevale, Roberto; Violi, Francesco
• Is Part Of: Journal of the American Heart Association. Volume 3:Issue 4(2014:Aug.)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2014-07-02
• Subjects: antioxidant -- atherosclerosis -- chocolate -- oxidant stress -- peripheral vascular disease; Heart -- Diseases -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; Cerebrovascular disease -- Periodicals; Cardiology -- Periodicals; 616.1
• DOI: 10.1161/JAHA.114.001072
• Languages: English
• ISSNs: 2047-9980

Abstract

Abstract : Background: NOX‐2, the catalytic subunit of NADPH oxidase, has a key role in the formation of reactive oxidant species and is implicated in impairing flow‐mediated dilation (FMD). Dark chocolate exerts artery dilatation via down‐regulating NOX2‐mediated oxidative stress. The aim of this study was to investigate whether dark chocolate improves walking autonomy in peripheral artery disease (PAD) patients via an oxidative stress‐mediated mechanism. Methods and Results: FMD, serum levels of isoprostanes, nitrite/nitrate (NOx) and sNOX2‐dp, a marker of blood NOX2 activity, maximal walking distance (MWD) and maximal walking time (MWT) were studied in 20 PAD patients (14 males and 6 females, mean age: 69±9 years) randomly allocated to 40 g of dark chocolate (>85% cocoa) or 40 g of milk chocolate (≤35% cocoa) in a single blind, cross‐over design. The above variables were assessed at baseline and 2 hours after chocolate ingestion. Dark chocolate intake significantly increased MWD (+11%; P <0.001), MWT (+15%; P <0.001), serum NOx (+57%; P <0.001) and decreased serum isoprostanes (−23%; P =0.01) and sNOX2‐dp (−37%; P <0.001); no changes of the above variables were observed after milk chocolate intake. Serum epicatechin and its methylated metabolite significantly increased only after dark chocolate ingestion. Multiple linear regression analysis showed that Δ of MWD was independently associated with Δ of MWT ( P <0.001) and Δ of NOx ( P =0.018). In vitro study demonstrated that HUVEC incubated with a mixture of polyphenols significantly increased nitric oxide ( P <0.001) and decreased E‐selectin ( P <0.001) and VCAM1 ( P <0.001). Conclusion: In PAD patients dark but not milk chocolate acutely improves walking autonomy with a mechanism possibly related to an oxidative stress‐mediated mechanism involving NOX2 regulation. Clinical Trial Registration: URL:http://www.clinicaltrials.gov . Unique identifier: NCT01947712.